Skip to main content

Animations

MJFF Publications

691 - 700 of 8571 Results
Title
Year
  • Year
  • 2017
  • 2022
  • 2019
  • 2022
  • 2021
  • 2013
  • 2018
  • 2021
  • 2019
  • 2021
  • Summary Details
    RESTRICTED
    Title: Inflammatory profile discriminates clinical subtypes in LRRK2‐associated Parkinson's disease
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/ene.13223
    Best OA location URL:
    Citation Count: 54
  • Summary Details
    OPEN
    Title: Cathepsin B p.Gly284Val Variant in Parkinson’s Disease Pathogenesis
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms23137086
    Citation Count: 15
  • Summary Details
    RESTRICTED
    Title: Exosome/microvesicle content is altered in leucine‐rich repeat kinase 2 mutant induced pluripotent stem cell‐derived neural cells
    Journal Name: Journal of Comparative Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/cne.24819
    Best OA location URL:
    Citation Count: 14
  • Summary Details
    RESTRICTED
    Title: Reply to: “Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations”?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29136
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: echolocatoR: an automated end-to-end statistical and functional genomic fine-mapping pipeline
    Journal Name: Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/bioinformatics/btab658
    Citation Count: 27
  • Summary Details
    RESTRICTED
    Title: The KV7.2/3 preferring channel opener ICA 27243 attenuates L-DOPA-induced dyskinesia in hemiparkinsonian rats
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2013.04.017
    Best OA location URL:
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: Brain and gut: Partners in crime
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27407
    Best OA location URL:
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Characterization of extracellular vesicles and synthetic nanoparticles with four orthogonal single‐particle analysis platforms
    Journal Name: Journal of Extracellular Vesicles
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/jev2.12079
    Citation Count: 149
  • Summary Details
    RESTRICTED
    Title: Progressive loss of raphe nuclei serotonin transporter in early Parkinson's disease: A longitudinal 123I-FP-CIT SPECT study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.03.025
    Best OA location URL:
    Citation Count: 38
  • Summary Details
    RESTRICTED
    Title: Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonist
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108693
    Citation Count: 17
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.